Theophylline, a methylxanthine derivative, suppresses absence epileptic seizures in WAG/Rij rats
Related Experiment Video
Updated: Aug 22, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Nurbay Ates1, Deniz Sahin, Gül Ilbay
1Department of Physiology, Faculty of Medicine, Kocaeli University, 41900, Derince, Kocaeli, Turkey. nates@kou.edu.tr <nates@kou.edu.tr>
Abstract:
The effects of systemic theophylline administration on spike-wave discharge (SWD) frequency in genetically absence epileptic Wistar Albino Glaxo/Rijswijk (WAG/Rij) rats are investigated. After an hour of baseline recording, animals were injected intraperitoneally (ip) with 5, 10, and 20mg/kg theophylline and electroencephalograms (EEGs) were recorded for 2h postinjection. Then, the number and total duration of SWDs were analyzed. Spontaneous behaviors of the animals was also observed before and after drug administration. Our results show that systemic administration of theophylline suppresses the occurrence of SWDs in a dose-dependent manner. The greatest suppression was seen in the group administered 20mg/kg theophylline. Theophylline also induced a mild increase in exploratory and automatic behavior. These results indicate that blockage of adenosinergic receptors via the methylxanthine derivative theophylline decreases the occurrence of SWDs, probably by augmenting the efficacy of excitator neurotransmission and increasing vigilance and arousal levels.
More Related Videos
09:06Manipulation of Epileptiform Electrocorticograms (ECoGs) and Sleep in Rats and Mice by Acupuncture
Published on: December 22, 2016
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Related Concept Videos
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists